![]() |
![]() |
|
![]() |
||
Channels: Astrology | Broadband | Contests | E-cards | Money | Movies | Romance | Search | Women Partner Channels: Bill Pay | Health | IT Education | Jobs | Travel |
||
![]() |
||
Home >
Money > Reuters > Report August 29, 2001 |
Feedback
|
|
Dr Reddy's files for generic Zofran in USDrugmaker Dr Reddy's Laboratories said it has filed for US marketing approvals for three forms of the generic version of GlaxoSmithKline Plc's Zofran drug. It said in a statement released late on Tuesday an application had been filed with the US Food and Drug Administration for marketing ondansetron in the 4 mg, 8 mg and 24 mg dosage form. Ondansetron is the main chemical ingredient in the anti-emetic Zofran. The New York Stock Exchange-listed Dr Reddy's said that GlaxoSmithKline has filed a lawsuit against the company alleging patent infringement. "Dr Reddy's believes that it has the first to file status for all the three strengths and if successful in its litigation, would enjoy a 180-day exclusivity on the product," the company said. On the NYSE the company's American Depositary Receipts fell 0.76 per cent to $23.42 on Tuesday. Two ADRs equal one Indian-listed share.
|
ADVERTISEMENT |